Total
0
Shares
Holista Colltech’s (ASX:HCT) sanitiser orders spike following coronavirus outbreak
  • Rising coronavirus fears have ignited demand for Hollister Colltech's (HTC) NatShield Sanitiser in Kuala Lumpur
  • The company has already sold out of its sanitising spray in Malaysia's capital
  • To combat rising demand for Natshield, Holista plans to airfreight 60,000 bottles of the disinfectant to 3000 pharmacies throughout Malaysia
  • This will occur by mid-February
  • So far, the coronavirus has wreaked havoc worldwide, responsible for the deaths of 132 people in China
  • Holista is now trading at a 2.6 per cent increase, with shares selling for 7.9 cents each

Rising coronavirus fears have ignited demand for Hollister Colltech's (HTC) NatShield Sanitiser in Kuala Lumpur.

The company has already sold out of its sanitising spray in Malaysia's capital, where it's been out of stock since mid-January following the outbreak last month.

Now, to combat rising demand for Natshield, Holista plans to airfreight 60,000 bottles of the disinfectant to 3000 pharmacies throughout Malaysia by mid-February.

Path-Away protection

"The Path-Away® formula has been proven ... to be able to kill over 170 deadly pathogens, including previously existing forms of coronaviruses. Path-Away® is currently undergoing testing on the newly emerged coronavirus designated as the 'Wuhan Virus.'"

Dr. Arthur Martin, President of GICC

Each Natshield sanitising spray contains a five per cent dose of Path-Away, a powerful antimicrobial compound developed by Global Infection Control Consultants.

It's a plant-derived treatment that's previously been approved by the U.S. Food and Drug Administration (FDA) and the World Health Organisation (WHO).

Path-Away uses an active organic substance that weakens a virus' cell walls, causing them to clump together and kill themselves almost instantaneously.

According to Holista, Path-Away is free from toxic chemicals and alcohol — making it safe to use as a disinfectant on humans and pets.

“This is not a drug. It acts by sanitising body parts. It had been consistently shown to be effective and safe to users and the environment in the most advanced biosafety laboratories in the world”

Dr Rajen Manicka, CEO of Holista

The NatShield disinfectant was initially created to treat previously known strands of the coronavirus. According to Holist CEO Rajen Manicka, three to five sprays is all that's needed to disinfect hands, toilet seats, doorknobs, countertops and trolley bars for up to two hours.

The coronavirus

So far, the coronavirus has wreaked havoc worldwide, responsible for the deaths of 132 people in China.

WHO first became aware of the novel virus on New Year's Eve, which originated in the city of Wuhan.

Now, the virus has spread to 17 countries, including the U.S., Canada, France, Australia, Japan, South Korea and Nepal. Some have even begun evacuating citizens to protect them from the outbreak.

Similar to Severe Acute Respiratory Syndrome (SARS), the coronavirus is a contagious respiratory illness that originated in China.

Symptoms of the virus include fever, coughing, sore throats, fatigue and shortness of breath.

According to the New York Times, the number of known cases in China increased by a third overnight. Worldwide, nearly 6000 people are now diagnosed with the virus.

Aussie markets react

Thus far, five cases of the coronavirus have been confirmed in Australia. But scientists on the east coast have managed to recreate the virus in a laboratory this morning in a move that's put us one step closer to creating a cure.

In the meantime, global fear has weighed heavily on Aussie stocks. The ASX suffered its heaviest loss in 2020 yesterday, tumbling 97 points to hit 6993 and wipe a week's worth of gains.

Meanwhile, Australian companies like Biotron (ASX:BIT) could be working on a cure for the coronavirus. The biotech researcher filed a U.S. patent that mentioned the virus and treatments in late December, and shares soared more than 40 per cent last week following market speculation.

AuMake (ASX:AU8) shares, however, have been hit hardest by virus fears. The company's shaved 18.4 per cent from its share price to hit a record low on Tuesday, falling to 9.4 cents each. AuMake announced a Chinese travel ban would impact its business, which operates as a daigou distribution channel.

Holista shares experienced a slight spike following the market update. The company is now trading at a 2.6 per cent increase, with shares selling for 7.9 cents each at 12:36 pm AEDT.


Subscribe


HCT by the numbers
More From The Market Herald
Incannex Healthcare (ASX:IHL) - Chief Medical Officer, Dr Sud Agarwal (left) & CEO, Joel Latham (right) - The Market Herald

" Incannex Healthcare (ASX:IHL) receives ethics approval for OSA trial

Medicinal cannabis company Incannex Healthcare (IHL) has received ethics approval for a phase 2b clinical trial investigating its obstructive sleep apnoea (OSA) treatment.
Westpac (ASX:WBC) - CEO, Peter King - The Market Herald

" Westpac (ASX:WBC) to pay $1.3B to settle AUSTRAC case

Westpac Banking Corporation (WBC) has agreed to pay $1.3 billion to settle its case with AUSTRAC in the Federal Court of Australia.
Afterpay (ASX:APT) - CEO, Anthony Eisen - The Market Herald

" Afterpay (ASX:APT) shakes up executive team

A new day of trade has brought with it leadership changes at buy now, pay later giant Afterpay (APT).
MyFiziq (ASX:MYQ) - CEO & Co Founder, Vlado Bosanac - The Market Herald

" MyFiziq (ASX:MYQ) JV completes $2M funding round

MyFiziq (MYQ) joint venture company, Body Composition Technologies, has completed a $2 million funding round.